newscontact us

CESCA THERAPEUTICS ANNOUNCES FISCAL THIRD QUARTER AND NINE MONTH 2017 FINANCIAL AND OPERATING RESULTS AND PROVIDES CORPORATE UPDATE

RANCHO CORDOVA, CA, May 11, 2017 – Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced financial and operating results for the fiscal third quarter and nine months ended March 31, 2017 and provided a corporate update…(more)